St. Joseph’s Hospital’s Structural Heart and Valve Program has received recertification from the American College of Cardiology (ACC), signaling continued recognition for its performance in transcatheter valve repair and replacement procedures. The ACC’s Transcatheter Valve Certification involves an external review process that uses national clinical databases to track patient safety and outcomes, requiring participating hospitals to contribute data for ongoing evaluation.
The hospital reports that its program has completed over 1,500 transcatheter aortic valve replacement (TAVR) procedures since it began. It was also among the first in Florida to use the Edwards Resilia treated S3 Ultra intra-annular valve, expanding treatment options for patients who require TAVR.
Following its initial ACC certification in 2022, St. Joseph’s Hospital saw improved success rates in procedures, which hospital officials attribute partly to detailed pre-operative evaluations conducted by a multidisciplinary team of six physicians from different specialties.
“ACC recertification represents months of hard work by the St. Joseph’s Hospital’s Structural Heart and Valve Team in conjunction with our Heart and Vascular Institute colleagues,” said Phillips Harrington, MD, director of the St. Joseph’s Hospital’s Structural Heart and Valve Program and a BayCare Medical Group cardiothoracic surgeon. “The ACC sets the highest standard for Transcatheter Valve Programs and the St. Joseph’s [Hospital] team is proud to achieve this important recognition.”
BayCare operates two other ACC-accredited structural heart programs: one at Winter Haven Hospital’s Bostick Heart Center in Winter Haven, and another at Morton Plant Hospital’s Center for Advanced Valve and Structural Heart Care in Clearwater. BayCare officials state that collaboration across these three hospitals distinguishes their structural heart programs within the region.
Further details about BayCare’s TAVR services can be found at BayCare’s TAVR services.
